2013;6:535 42. S4.3.6-2. Fraisse A, Assaidi A, Mauri L, et al. Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: incidence, diagnosis, and outcome. Catheter Cardiovasc Interv. 2014;83:E260 8. S4.3.6-3. McElhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292 300. S4.3.6-4. McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011;4:602 14. S4.3.6-5. Mainwaring RD, Pirolli T, Punn R, et al. Late repair of the native pul- monary valve in patients with pulmonary insufficiency after surgery for tetralogy of Fallot. Ann Thorac Surg. 2012;93:677 9. S4.3.6-6. Bauer BS, Zachariah S, Levi D, et al. Evaluation of peak pressure gradients in patients after Melody valve implantation: a compar- ison of cardiac catheterization and doppler echocardiography. Echocardiography. 2015;32:1073 9. CLINICAL STATEMENTS AND GUIDELINES S4.3.6-7. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US Melody valve trial. Circulation. 2010;122:507 16. S4.3.6-8. Niemantsverdriet MBA, Ottenkamp J, Gauvreau K, et al. Determinants of right ventricular outflow tract conduit longevity: a multinational analysis. Congenit Heart Dis. 2008;3:176 84. S4.3.6-9. Batra AS, McElhinney DB, Wang W, et al. Cardiopulmonary exer- cise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial. Am Heart J. 2012;163:280 7. S4.3.6-10. Zahn EM, Hellenbrand WE, Lock JE, et al. Implantation of the Melody transcatheter pulmonary valve in patients with a dysfunc- tional right ventricular outflow tract conduit early results from the US clinical trial. 